StockData
Sarepta Therapeutics, Inc. logo

Sarepta Therapeutics, Inc. (SRPT) stock

SRPTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3086% below fair value
$14.77−0.36 (-2.38%)

Close on Nov 17, 2026Market cap $1.56BP/E –Yield –

Sarepta Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Sarepta Therapeutics's price to book ratio was 1.2× on Nov 11, 2026, against 1.5× a year earlier. Over the last 5 years it ranged from 1.0× to 31.5×, with a median of 9.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.2×−0.4
2025Dec 31, 20251.5×−8.0
2024Dec 31, 20249.5×−2.3
2023Dec 29, 202311.8×−14.6
2022Dec 30, 202226.4×+11.1
2021Dec 31, 202115.3×+0.3
2020Dec 31, 202015.1×+5.4
2019Dec 31, 20199.7×−1.7
2018Dec 31, 201811.4×+6.2
2017Dec 29, 20175.2×+1.5
2016Dec 30, 20163.6×−9.5
2015Dec 31, 201513.1×+11.0
2014Dec 31, 20142.1×−1.0
2013Dec 31, 20133.1×−38.5
2012Dec 31, 201241.6×+38.4
2011Dec 30, 20113.2×–

More Sarepta Therapeutics figures

See a number that looks wrong?